Family Management Corp - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 118 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 1.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
Family Management Corp ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$88,000
-18.5%
21,500
+26.5%
0.06%
-1.6%
Q3 2016$108,000
+44.0%
17,000
+21.4%
0.06%
+45.2%
Q2 2016$75,000
-21.1%
14,000
+16.7%
0.04%
-14.3%
Q4 2015$95,000
-20.2%
12,000
-14.3%
0.05%
-7.5%
Q3 2015$119,000
-51.2%
14,000
-31.7%
0.05%
-52.7%
Q1 2015$244,000
-33.5%
20,500
-36.9%
0.11%
-32.5%
Q4 2014$367,000
+114.6%
32,500
+66.7%
0.17%
+112.8%
Q3 2014$171,000
+67.6%
19,500
+39.3%
0.08%
+56.0%
Q2 2014$102,000
+43.7%
14,0000.0%0.05%
+35.1%
Q1 2014$71,000
-5.3%
14,0000.0%0.04%
-14.0%
Q4 2013$75,00014,0000.04%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q1 2017
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 2,244,080$12,096,0004.51%
ALTFEST L J & CO INC 39,491$1,653,0001.15%
GARRISON BRADFORD & ASSOCIATES INC 82,700$446,0000.44%
WESTFIELD CAPITAL MANAGEMENT CO LP 9,074,557$48,912,0000.40%
Virtus ETF Advisers LLC 87,477$472,0000.35%
Cannell & Co. 1,614,678$8,703,0000.32%
Birchview Capital, LP 44,000$237,0000.17%
STONERIDGE INVESTMENT PARTNERS LLC 180,534$973,0000.14%
HighPoint Advisor Group LLC 8,484$344,0000.12%
MARINER INVESTMENT GROUP LLC 63,090$340,0000.12%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders